Gadoterate Meglumine Injection
Product Images NDC 65219-088

This is a description of Gadoterate Meglumine Injection, USP. It is a sterile solution with 0.5 mmol per mL used for intravenous administration. The medication comes in a Pharmacy Bulk Package, which is not for direct infusion. Each vial contains 100 mL of the solution, and it should be withdrawn within 24 hours of initial puncture. The medication guide must be dispensed to each patient. The usual dosage is described in the package insert. The manufacturing company is Hll Fresenius, located in Lake Zurich, IL, and the product is made in China. The NDC number for this medication is 65219-088-06. Each mL of the solution contains 3769 mg of Gadoterate meglumine, 0.25mg of DOTA, and water for injection.*

This is a description of the Pharmacy Bulk Package of Gadoterate Meglumine Injection, USP. It is a sterile solution with a concentration of 50 mmol per 100 ml, used for intravenous administration with a suitable transfer device. The contents of the package must be used within 24 hours after initial puncture, and any unused portion must be discarded. The usual dosage is indicated in the package insert. The 100 ml multiple dose vial should not be used for direct infusion. Each ml contains 3769 mg of gadoterate meglumine, 0.25 mg of DOTA, and water for injection. The solution must be stored between 15° to 30°C (59° to 86°F). The manufacturer is indicated as Schering AG Zurich, L. 60047, Made in China, and the product is assigned with NDC65219-08806.*